Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Notes Payables (2024 - 2026)

Orthopediatrics has reported Notes Payables over the past 3 years, most recently at $172000.0 for Q1 2026.

  • For Q1 2026, Notes Payables changed N/A year-over-year to $172000.0; the TTM value through Mar 2026 reached $172000.0, changed N/A, while the annual FY2025 figure was $170000.0, 88.11% down from the prior year.
  • Notes Payables for Q1 2026 was $172000.0 at Orthopediatrics, up from $170000.0 in the prior quarter.
  • Over five years, Notes Payables peaked at $1.4 million in Q4 2024 and troughed at $170000.0 in Q4 2025.
  • A 3-year average of $769250.0 and a median of $738500.0 in 2025 define the central range for Notes Payables.
  • On a YoY basis, Notes Payables climbed as much as 88.11% in 2025 and fell as far as 88.11% in 2025.
  • Year by year, Notes Payables stood at $1.4 million in 2024, then plummeted by 88.11% to $170000.0 in 2025, then rose by 1.18% to $172000.0 in 2026.
  • Business Quant data shows Notes Payables for KIDS at $172000.0 in Q1 2026, $170000.0 in Q4 2025, and $1.3 million in Q3 2025.